These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3956050)

  • 21. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.
    Vesell ES; Passananti GT; Glenwright PA; Dvorchik BH
    Clin Pharmacol Ther; 1975 Sep; 18(3):259-72. PubMed ID: 1164816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipyrene clearance in Indian villagers.
    Desai NK; Sheth UK; Mucklow JC; Fraser HS; Bulpitt CJ; Jones SW; Dollery CT
    Br J Clin Pharmacol; 1980 Apr; 9(4):387-94. PubMed ID: 7378255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipyrine disposition in milk and saliva of lactating women.
    Berlin CM; Vesell ES
    Clin Pharmacol Ther; 1982 Jan; 31(1):38-44. PubMed ID: 7053302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further study on the effect of norethisterone enanthate, an injectable contraceptive on body functions.
    Ali MN; Jalil MA
    Bangladesh Med Res Counc Bull; 1978 Dec; 4(2):63-70. PubMed ID: 575036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis.
    el-Raghy I; Back DJ; Osman F; Nafeh MA; Orme ML
    Br J Clin Pharmacol; 1985 Oct; 20(4):313-6. PubMed ID: 4074599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of antipyrine kinetics by measurement in saliva.
    Fraser HS; Mucklow JC; Murray S; Davies DS
    Br J Clin Pharmacol; 1976 Apr; 3(2):321-5. PubMed ID: 973966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical exercise and improvement of liver oxidative metabolism in the elderly.
    Mauriz JL; Tabernero B; García-López J; Jorquera F; Villa JG; González-Gallego J
    Eur J Appl Physiol; 2000 Jan; 81(1-2):62-6. PubMed ID: 10552268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of injectable contraceptive on lipid metabolism in women.
    Kandeel KM; Nayel SA; Abaza MS
    Biomed Biochim Acta; 1984; 43(1):111-5. PubMed ID: 6721873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of norethisterone oenanthate and predisposition to thrombosis.
    Afsar NA; Barakzai Q; Adil SN
    J Coll Physicians Surg Pak; 2004 Sep; 14(9):556-9. PubMed ID: 15353142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on theophylline metabolism: autoinduction and inhibition by antipyrine.
    Denlinger CL; Stryker KK; Slusher LB; Vesell ES
    Clin Pharmacol Ther; 1987 May; 41(5):522-30. PubMed ID: 3568537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in blood sugar, protein, and lipid levels in Indian women by norethisterone enanthate.
    Chaudhuri C; Bhowmik T; Mukherjea M
    Int J Fertil; 1987; 32(3):240-4. PubMed ID: 2885291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of antipyrine in epileptic patients.
    Rimmer EM; Routledge PA; Tsanaclis LM; Richens A
    Br J Clin Pharmacol; 1986 May; 21(5):511-4. PubMed ID: 3718808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of norethindrone acetate in women.
    Singh H; Uniyal JP; Jha P; Murugesan K; Takkar D; Hingorani V; Laumas KR
    Am J Obstet Gynecol; 1979 Oct; 135(3):409-14. PubMed ID: 484634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men.
    Qoubaitary A; Meriggiola C; Ng CM; Lumbreras L; Cerpolini S; Pelusi G; Christensen PD; Hull L; Swerdloff RS; Wang C
    J Androl; 2006; 27(6):853-67. PubMed ID: 16837736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fertility inhibition by an injectable progestogen acting for 3 months. A clinical survey of 130 fertile women treated with norethisterone enanthate.
    Zañartu J; Navarro C
    Obstet Gynecol; 1968 May; 31(5):627-33. PubMed ID: 5651111
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of oral contraceptives on plasma clearance.
    Carter DE; Bressler R; Hughes MR; Haussler MR; Christian D; Heine MW
    Clin Pharmacol Ther; 1975 Dec; 18(6):700-7. PubMed ID: 173489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipyrine clearance during occupational exposure to styrene.
    Døssing M
    Br J Ind Med; 1983 May; 40(2):224-8. PubMed ID: 6131688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal variations of antipyrine half-life in man.
    Vesell ES; Shively CA; Passananti GT
    Clin Pharmacol Ther; 1977 Dec; 22(6):843-52. PubMed ID: 923179
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of a 'progestin only' contraceptive on platelet aggregation in a Pakistani set of population.
    Afsar NA; Barakzai Q; Adil SN
    J Ayub Med Coll Abbottabad; 2005; 17(3):21-5. PubMed ID: 16320790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of antipyrine kinetics from saliva or plasma: influence of age.
    Jorquera F; Almar MM; Jimeno A; González-Sastre M; González-Gallego J
    J Pharm Biomed Anal; 1995 Aug; 13(9):1141-5. PubMed ID: 8573640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.